QLT (QLTI)
QLT Revenues: 8.992M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
QLTI Revenues Rankings
| Overall | 12th percentile | 3883 of 4432 |
| Sector | 30th percentile | 325 of 471 in Healthcare |
| Industry | 47th percentile | 69 of 132 in Biotechnology |
QLTI Revenues Range, Past 5 Years
| Minimum | 8.585M | Sep 2010 |
| Maximum | 39.01M | Dec 2008 |
| Average | 17.46M |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity.
Learn More
You may also be interested in these QLTI related companies
QLTI News
QLT Inc. (QLTI) Indicated Higher; Shareholder Axial Capital May Be in Discussion w/ Management
May 25, 6:42AM Street Insider
May 25, 6:42AM Street Insider
QLT Inc. (QLTI) Announces Board Will Propose $75-$100M Dutch Auction Tender Offer
May 24, 4:29PM Street Insider
May 24, 4:29PM Street Insider
QLT Inc. (QLTI) Issues Response to Nordic Biotech Notification on Board Nominees
May 23, 8:57AM Street Insider
May 23, 8:57AM Street Insider
QLT Inc. (QLTI) Says Nordic Biotech to Vote 7.4M Common in Favor of Nominees
May 23, 8:56AM Street Insider
May 23, 8:56AM Street Insider
QLT Announces Notification of Legal Proxy Action in Advance of Annual Meeting of Stockholders
May 23, 6:30AM GlobeNewswire
May 23, 6:30AM GlobeNewswire
$QLTI Insider Buy: $333K of stock bought by Florian Schonharting on May 16, 2012 http://stks.co/3tlU
about 14 days ago by MarketBrief
about 14 days ago by MarketBrief
Media Advisory: QLT to Report First Quarter Financial Results on May 3, 2012
Apr 19, 6:30AM GlobeNewswire
Apr 19, 6:30AM GlobeNewswire
QLT Announces the Appointment of Christopher Muller as Chief Commercial Officer
Apr 16, 6:30AM GlobeNewswire
Apr 16, 6:30AM GlobeNewswire
QLT's CEO Presents at 30th Annual JPMorgan Healthcare Conference - Conference Call Transcript
Mar 09, 2:46PM Seeking Alpha
Mar 09, 2:46PM Seeking Alpha
Media Advisory: QLT to Present at ROTH Capital Partners Annual Growth Stock Conference
Mar 08, 6:30AM GlobeNewswire
Mar 08, 6:30AM GlobeNewswire
QLT Inc. (QLTI) Reports Positive Preliminary Results From Phase 1b Trial of QLT091001
Mar 01, 6:52AM Street Insider
Mar 01, 6:52AM Street Insider
Media Advisory: QLT to Present at the 2012 RBC Capital Markets' Global Healthcare Conference
Feb 23, 4:10PM GlobeNewswire
Feb 23, 4:10PM GlobeNewswire
$QLTI http://stks.co/2TBv having exited from high and tight flag on daily
about 104 days ago by traderdigs
about 104 days ago by traderdigs
$QLTI http://stks.co/2TBt bit late but wanted to pt out nice xo for this flu stock in 30min @adxguy
about 104 days ago by traderdigs
about 104 days ago by traderdigs
Media Advisory: QLT to Report 2011 Fourth Quarter and Year End Financial Results on February 23, 2012
Feb 16, 4:10PM GlobeNewswire
Feb 16, 4:10PM GlobeNewswire
5 Small Cap Health Services Stocks To Watch http://stks.co/2Mka $BIOS $EXAM $MRGE $QLTI $ZIOP
about 109 days ago by waterburyresearch
about 109 days ago by waterburyresearch
Media Advisory: QLT to Present at the Leerink Swann 2012 Global Healthcare Conference
Feb 08, 6:30AM GlobeNewswire
Feb 08, 6:30AM GlobeNewswire
MEDIA ADVISORY: QLT to Present at the J.P. Morgan Healthcare Conference
Jan 09, 6:30AM GlobeNewswire
Jan 09, 6:30AM GlobeNewswire
$QLTI 200 Day SMA Cross - Price crossed above 200 day SMA (7.0748). Confirmed by volume.
about 163 days ago by TradeIdeasQuant
about 163 days ago by TradeIdeasQuant
Media Advisory: QLT to Host Research and Development Day in New York City on December 16, 2011
Dec 08, 6:30AM GlobeNewswire
Dec 08, 6:30AM GlobeNewswire
$QLTI $6.91 CLARKE C BOYD director P 4,000 @ $6.75 amnt $27,000 proc'd $640 6/17/2011
about 346 days ago by canarionyc
about 346 days ago by canarionyc
$QLTI http://chart.ly/agvcvi5 Flag #Pattern BO, T~$8+ inside CnH Pattern, T~$9.5; Bullish $Flow; #Wave C, T~$9.6; Long Jul calls
about 366 days ago by RatioCynic
about 366 days ago by RatioCynic
$QLTI treatment of eye disease w/ ocular drugs/devices: retinal, glaucoma, ocular hypertension-increasing probs of aging boomer population
about 420 days ago by abubnic
about 420 days ago by abubnic
$QLTI coverage initiated with "outperform" at Leerink. Target: $12-$13/share.
about 420 days ago by abubnic
about 420 days ago by abubnic
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| QLTI | 7.61 | +0.03 | +0.40% | 371.12M |
| QLT | 23.95 | +0.23 | +0.97% | |
| QLIK | 22.73 | -0.40 | -1.73% | 1.954B |
| QLGC | 13.61 | -0.20 | -1.45% | 1.363B |
| QLD | 49.87 | -0.43 | -0.85% | |
| QIHU | 20.00 | -0.53 | -2.58% | 702.54M |
| QID | 35.26 | +0.30 | +0.86% | |
| QGEN | 16.00 | -0.25 | -1.54% | 3.806B |
| QEP | 26.32 | +0.15 | +0.57% | 4.645B |
| QDEL | 15.72 | +0.18 | +1.16% | 513.91M |